Reading size

PACK IN HAND · ONE-PAGE CHECK

Medicine pack check sheet

Print this sheet or fill it in before speaking with a pharmacist or clinician. Copy only what is printed on the pack in hand. The published fields below are starting points from this record, not proof that your pack is the same product.

Published record starting point

Record display name
Lanoxin
Generic name / active ingredient
digoxin
Dosage-form class
Oral tablets: 62.5 mcg, 125 mcg and 250 mcg (as listed in the current U.S. tablet label)
Route
Oral
Record reviewed
2026-08-19

Copy from the pack in hand

Source-linked reading points

  • 1 mg = 1000 mcg. The 62.5/125/250 mcg labels equal 0.0625/0.125/0.25 mg respectively; 125 mg is not 125 mcg but a thousand-fold larger. This relationship prevents unit misreading; it is not a personal dose converter.
  • The 125 mcg tablet appears in both a 100-tablet bottle and an institutional unit-dose pack, so NDC and pack still matter. A different pack does not automatically change the amount per tablet or determine an individual's tablet count.
  • The 62.5 mcg tablet is unscored; the 125 mcg and 250 mcg tablets are labelled as scored. A score is an appearance clue for an exact presentation, not permission for a webpage to decide whether or how someone splits a tablet.
  • LANOXIN injection has a different NDA, SPL, route and concentration expression; generic digoxin oral solution is also not this tablet record. A shared brand or generic name does not support self-conversion by mcg, mL or route.

Reviewed presentation examples — compare every field

  • 62.5 mcg per tablet; 100-tablet bottleNDC 59212-240-55
  • 125 mcg per tablet; 100-tablet bottleNDC 59212-242-55
  • 125 mcg per tablet; institutional unit-dose pack (10 blisters × 10 tablets)NDC 59212-242-56
  • 250 mcg per tablet; 100-tablet bottleNDC 59212-249-55

EDITORIAL RECORD

Who prepared and checked this page

Byline
OriginDrug Content Editorial
Review role
Public primary-source verification
Last reviewed
2026-08-19
Source record
1 clickable primary-source entry point is listed with this dossier.

The review role checks source traceability, stated market, document version and product-identity fields. It is not a claim of clinical licensure, prescribing authority or individual pharmacy service. Read the editorial policy.

Search records
Enlarged public-label image